Can I Take Levitra (Vardenafil) While Breastfeeding?

Published on September 4th, 2026.

Key takeaways

  • No human breast milk data exists for vardenafil, so unknown risk is the honest answer.

  • Vardenafil's short half-life may allow feed timing, but this lacks formal validation.

  • Medical necessity, like pulmonary hypertension, changes the risk-benefit calculation significantly.

  • Sildenafil has marginally more lactation research and may be worth discussing with your doctor.

  • Never self-stop a serious medication without guidance from a prescriber or lactation specialist.

Is Vardenafil Safe to Take While Breastfeeding?

The honest answer is that nobody knows for certain, and that matters more than it might sound. No published human studies have measured vardenafil in breast milk, so clinicians cannot tell you it is safe. Most advise caution or avoidance while nursing. If you have been prescribed this medication and are breastfeeding, a conversation with your doctor is not optional; it is urgent.

Vardenafil (sold as Levitra) is FDA-approved to treat erectile dysfunction in men. Any use in women, including postpartum women, is off-label, meaning it falls outside the conditions the drug was formally studied for. The absence of safety data is not a green light. When a nursing infant is involved, "we don't know" should be treated the same way you would treat a known risk.

What Do We Actually Know About Vardenafil in Breast Milk?

The short answer is: very little. The NIH database LactMed, which is the most widely used clinical reference for drug safety during breastfeeding, lists vardenafil with insufficient data to assess infant risk. No controlled studies exist.

That said, a few pharmacological facts are worth understanding:

  • Half-life of 4 to 5 hours. This is how long it takes your body to clear half a dose. A shorter half-life generally means the drug leaves your system faster, which matters for timing feeds.
  • Moderate molecular weight. Smaller molecules tend to transfer into breast milk more easily. Vardenafil's weight falls in a range that makes transfer plausible.
  • Lipophilic (fat-soluble) properties. Fat-soluble drugs can concentrate in breast milk, which is naturally high in fat. Animal studies support this concern for vardenafil.

None of these facts confirm transfer happens at levels that harm an infant. They do confirm that assuming it is safe would be a mistake.

Why Would a Breastfeeding Woman Be Prescribed Vardenafil?

This question matters because the reason shapes the risk-benefit conversation entirely.

  • Pulmonary arterial hypertension (high blood pressure in the lungs): PDE5 inhibitors, the drug class that includes vardenafil, are a legitimate treatment for this serious condition. Stopping the drug without a plan could be life-threatening.
  • Raynaud's phenomenon (painful blood vessel spasms, often in fingers and toes): An off-label use where PDE5 inhibitors sometimes help. Less urgent than pulmonary hypertension.
  • Postpartum sexual dysfunction: Vardenafil is not approved or recommended for women in standard guidelines. This would be considered elective use, and the risk-benefit math looks very different than for a serious medical condition.

If your prescription is for something medically necessary, do not stop taking it on your own. Work with your prescriber to find the safest path forward.

How Do Vardenafil, Sildenafil, and Tadalafil Compare for Nursing Mothers?

All three drugs belong to the same class and share the same core concern during breastfeeding. The table below reflects what is currently known and where each drug sits on the caution spectrum.

Drug

Half-Life

Lactation Data Available

Relative Caution While Breastfeeding

Vardenafil (Levitra)

4 to 5 hours

None in humans

High caution; avoid if possible

Sildenafil (Viagra, Revatio)

3 to 5 hours

Very limited; slightly more than vardenafil

Moderate-high caution; may be preferred for PAH

Tadalafil (Cialis)

Up to 17 hours

Minimal human data

High caution; long half-life increases cumulative infant exposure risk

Sildenafil has a slight edge in lactation research, mostly from its use in treating pulmonary hypertension in women of childbearing age. It is not proven safe, but a specialist may consider it a more informed choice in medically necessary cases. Tadalafil's much longer half-life makes it harder to time feeds around and increases the window of potential infant exposure.

As the first AI legally authorized to practice medicine, Doctronic can help you prepare the right questions before your specialist appointment, any time of day.

What Signs of Drug Exposure Should I Watch for in My Baby?

If you are taking vardenafil and breastfeeding, even temporarily, watch your infant closely. Vardenafil's main mechanism is lowering blood pressure. Possible signs of exposure in a newborn include:

  • Unusual limpness or low muscle tone
  • Poor feeding or significant changes in feeding patterns
  • Blue-tinged skin (cyanosis), especially around the lips
  • Extreme sleepiness that is hard to explain

Premature infants and low-birth-weight babies face higher risk because their livers and kidneys clear drugs more slowly than full-term newborns.

Keeping a simple log of feeding times and any unusual symptoms makes it much easier for a clinician to spot patterns quickly if a concern arises.

How Should I Talk to My Doctor About This?

This conversation is too important to leave vague. Come prepared with specific questions:

  • "Is my indication urgent enough that stopping or switching drugs would be risky?" This helps clarify whether you have options.
  • "Can you consult LactMed or a lactation pharmacologist before we finalize a plan?" Not every prescriber thinks to do this automatically.
  • "Is a pump-and-discard strategy reasonable for me, given my dose and feeding schedule?" Pumping and discarding milk for 10 to 15 hours after a dose (two to three half-lives) is sometimes suggested as a harm-reduction approach, though it has not been formally validated for this drug.
  • "Would sildenafil be a better fit for my condition while I am nursing?"

If in-person access to a specialist is limited, a telehealth visit is a practical way to get a fast second opinion. Doctronic's 24/7 platform connects you with clinicians whose treatment plans align with board-certified physicians at a 99.2% rate, for $39 a video visit.

One thing to be clear about: do not self-discontinue a medication prescribed for a serious condition like pulmonary hypertension. The risks of stopping abruptly can outweigh the theoretical risks of continued use while a plan is made.

Frequently Asked Questions

No human studies have measured vardenafil in breast milk. Its chemical properties suggest it could transfer, but the actual amount an infant might receive is unknown. Caution is the standard clinical recommendation until more data exists.

Some clinicians suggest waiting two to three half-lives, roughly 10 to 15 hours, before nursing after a dose. This strategy is not formally validated for breastfeeding mothers, so discuss timing with your prescriber before trying it.

Levitra is FDA-approved only for erectile dysfunction in men. Postpartum use in women is off-label and largely unstudied. Safety for a nursing mother and her infant cannot be confirmed with current evidence. A specialist consultation is strongly recommended.

None have robust lactation safety data, but sildenafil has slightly more postpartum research than vardenafil or tadalafil. For conditions like pulmonary hypertension, a specialist can weigh which option best balances your medical need against infant exposure risk.

Theoretically, yes. Vardenafil lowers blood pressure. Even small amounts transferred through milk could affect a newborn's cardiovascular system. Premature or low-birth-weight infants face higher risk due to reduced drug-clearance capacity.

The Bottom Line

Vardenafil's safety during breastfeeding is genuinely unknown, not proven safe and not proven harmful. The right answer for you depends on why it was prescribed, how old and healthy your baby is, and whether safer alternatives exist for your condition. A fast, documented conversation with your prescriber or a lactation pharmacologist is the most responsible next step. Doctronic offers 24/7 consultations, with 99.2% treatment plan alignment with board-certified physicians, so you can get expert guidance without waiting. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get women's health advice

Chat Now